Sangster-Guity, N <br/><br/>
ATR mediates cisplatin resistance in a p53 genotype-specific manner.  [electronic resource] 

 -  Oncogene  Jun 2011 
 - 2526-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2010.624  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--genetics<br/>Ataxia Telangiectasia Mutated Proteins<br/>Cell Cycle Proteins--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cisplatin--pharmacology<br/>Drug Resistance, Neoplasm--genetics<br/>Gene Knockdown Techniques<br/>Humans<br/>Neoplasms--genetics<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Tumor Suppressor Protein p53--genetics